Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodies... by Liping Sun, Haitian Quan, Chengying Xie, Lei Wang, Youhong Hu, Liguang Lou

Get full text

Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy by Kun Wang, Yingying Zhang, Zhaoming Su, Bei Wang, Yuanyang Zhou, Xiaochu Tong, Chengying Xie, Xiaomin Luo, Sulin Zhang, Mingyue Zheng

Get full text

Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS‐mutant Cancers by Yafang Wang, Lansong Xu, Lijun Ling, Mingyue Yao, Shangxuan Shi, Chengcheng Yu, Yingnian Li, Jie Shen, Hualiang Jiang, Chengying Xie

Get full text

Synthesis and Anticancer Activity Evaluation of Novel Carborane-Containing Isoflavonoid Analogues by Yirong Zhang, Chuwei Yu, Linyuan Wang, Lina Zhou, Chaofan Li, Changxian Yuan, Nan Sun, Guanxiang Hao, Chenyang Ma, Yuzhe Lin, Hongjing Li, Jiali Hong, Jinhua Zhao, Kaiyan Lou, Rui Zhang, Chengying Xie, Sinan Wang

Get full text